InvestSMART

Emyria Limited (ASX: EMD) - Announcements

Current share price for EMD : $0.046 0.001 (2.13%)+

ASX company news and announcements for Emyria Limited (EMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Emyria Limited (EMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Emyria Limited (EMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Emyria Limited (EMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$37 Application for quotation of securities - EMD 31 Oct 2025 7:43PM $0.057 $0.046 fallen by 19.30%
$37 September 2025 Quarterly Activities Report and Appendix 4C 27 Oct 2025 9:15AM $0.064 $0.046 fallen by 28.13%
$37 Application for quotation of securities - EMD 27 Oct 2025 8:16AM $0.064 $0.046 fallen by 28.13%
$37 Section 708A(5)(e) Notice 17 Oct 2025 6:33PM $0.068 $0.046 fallen by 32.35%
$37 Application for quotation of securities - EMD 17 Oct 2025 6:24PM $0.068 $0.046 fallen by 32.35%
$37 Medibank Expands Funding Agreement to Emyria Brisbane Clinic 15 Oct 2025 9:07AM $0.065 $0.046 fallen by 29.23%
$37 Company Presentation for Sharewise Webinar 15 Oct 2025 9:04AM $0.065 $0.046 fallen by 29.23%
$37 Emyria Webinar with Sharewise 13 Oct 2025 9:04AM $0.069 $0.046 fallen by 33.33%
$37 Application for quotation of securities - EMD 10 Oct 2025 6:06PM $0.069 $0.046 fallen by 33.33%
$37 Annual Report 10 Oct 2025 10:51AM $0.068 $0.046 fallen by 32.35%
$37 Appendix 4G and Corporate Governance Statement 10 Oct 2025 10:48AM $0.068 $0.046 fallen by 32.35%
$37 Letter to Shareholders - Notice of Annual General Meeting 10 Oct 2025 10:43AM $0.068 $0.046 fallen by 32.35%
$37 Notice of Annual General Meeting/Proxy Form 10 Oct 2025 10:42AM $0.068 $0.046 fallen by 32.35%
$37 Notification of cessation of securities - EMD 8 Oct 2025 3:02PM $0.064 $0.046 fallen by 28.13%
$37 Application for quotation of securities - EMD 3 Oct 2025 2:47PM $0.067 $0.046 fallen by 31.34%
$37 Change of Director's Interest Notice x 2 2 Oct 2025 6:15PM $0.069 $0.046 fallen by 33.33%
$37 Application for quotation of securities - EMD 30 Sep 2025 4:59PM $0.060 $0.046 fallen by 23.33%
$37 Notification regarding unquoted securities - EMD 22 Sep 2025 11:15AM $0.054 $0.046 fallen by 14.81%
$37 Notification of cessation of securities - EMD 22 Sep 2025 11:07AM $0.056 $0.046 fallen by 17.86%
$37 Emyria Secures Medibank Funding for Depression Care Program 22 Sep 2025 9:40AM $0.050 $0.046 fallen by 8%
$37 EMD Completes Sale of Less than Marketable Parcel at Premium 15 Sep 2025 8:56AM $0.047 $0.046 fallen by 2.13%
$37 Notice to Ineligible Shareholders of Loyalty Options Offer 15 Sep 2025 8:21AM $0.047 $0.046 fallen by 2.13%
$37 Notice to Eligible Shareholders of Loyalty Options Offer 9 Sep 2025 8:34AM $0.044 $0.046 risen by 4.55%
$37 Loyalty Options Prospectus 9 Sep 2025 8:22AM $0.044 $0.046 risen by 4.55%
$37 Change in substantial holding 8 Sep 2025 8:21AM $0.049 $0.046 fallen by 6.12%

76 - 100 of 566 results

Page 4 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.